 | • レポートコード：QYR2104Z2031 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、エボラ治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン（試験中）、治療薬（試験中））、用途別市場規模（病院、外来手術センター、専門クリニック、陸軍キャンプ（ベテラン施設））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・エボラ治療の市場動向 ・企業の競争状況、市場シェア ・エボラ治療の種類別市場規模（ワクチン（試験中）、治療薬（試験中）） ・エボラ治療の用途別市場規模（病院、外来手術センター、専門クリニック、陸軍キャンプ（ベテラン施設）） ・エボラ治療の北米市場規模2016-2027（アメリカ、カナダ） ・エボラ治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・エボラ治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エボラ治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・エボラ治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Arbutus Biopharma、GlaxoSmithKline、Johnson & Johnson Services、Hemispherx Biopharma、BioCryst Pharmaceuticals、NanoViricides、NewLink Genetics、Chimerix、Sarepta Therapeutics、Mapp Biopharmaceutical） ・結論 |
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash, muscular pain, etc. Ebola virus causes haemorrhagic fever which may lead to internal or external bleeding. The symptoms appear anywhere from 2 to 21 days after exposure to Ebola, though the average is 8 to 10 days. Diagnostic tests are now being done by ELISA (Antigen-capture enzyme-linked immunosorbent assay), Polymerase Chain Reaction, Virus Location, IgM Elisa and Immunohistochemistry testing. Few vaccines and medical treatments for Ebola are in pipeline and due to the absence of effective treatments, the pharmaceutical companies now have big opportunities in the market globally. As per WHO, several care rehydration methods are adopted with fluid injection orally and other treatments are also taken care of which improves the survival rate. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceuticals are among the key players in the global Ebola treatment market and are conducting trials on a set of experimental drugs.
The global Ebola treatment market growth is driven by the increasing incidence rates of Ebola viral infection and Ebola outbreaks. As per WHO, U.S. & U.K. governments, availability of different treatment procedures to treat Ebola is expected to drive the Ebola viral disease market growth during the forecast period. The Ebola treatment market also includes therapies for those who already have Ebola, and vaccines to prevent the deadly virus. Various drug companies and regulators in the U.S. are taking a two-pronged approach in finding a way to treat the virus. Approval of vaccines are taking a longer time but when vaccines undergo trials, adoption and availability could be a limiting factor for global Ebola treatment market growth.
Market Analysis and Insights: Global Ebola Treatment Market
The global Ebola Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ebola Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ebola Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ebola Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ebola Treatment market.
Global Ebola Treatment Scope and Market Size
Ebola Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ebola Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Vaccine (Under Trials)
Drugs (Under Trials)
Segment by Application
Hospitals
Ambulatory Surgery Centres
Specialized Clinics
Army Camps (Veteran Facilities)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Arbutus Biopharma
GlaxoSmithKline
Johnson & Johnson Services
Hemispherx Biopharma
BioCryst Pharmaceuticals
NanoViricides
NewLink Genetics
Chimerix
Sarepta Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ebola Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vaccine (Under Trials)
1.2.3 Drugs (Under Trials)
1.3 Market by Application
1.3.1 Global Ebola Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centres
1.3.4 Specialized Clinics
1.3.5 Army Camps (Veteran Facilities)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ebola Treatment Market Perspective (2016-2027)
2.2 Ebola Treatment Growth Trends by Regions
2.2.1 Ebola Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ebola Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Ebola Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Ebola Treatment Industry Dynamic
2.3.1 Ebola Treatment Market Trends
2.3.2 Ebola Treatment Market Drivers
2.3.3 Ebola Treatment Market Challenges
2.3.4 Ebola Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ebola Treatment Players by Revenue
3.1.1 Global Top Ebola Treatment Players by Revenue (2016-2021)
3.1.2 Global Ebola Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Ebola Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ebola Treatment Revenue
3.4 Global Ebola Treatment Market Concentration Ratio
3.4.1 Global Ebola Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ebola Treatment Revenue in 2020
3.5 Ebola Treatment Key Players Head office and Area Served
3.6 Key Players Ebola Treatment Product Solution and Service
3.7 Date of Enter into Ebola Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ebola Treatment Breakdown Data by Type
4.1 Global Ebola Treatment Historic Market Size by Type (2016-2021)
4.2 Global Ebola Treatment Forecasted Market Size by Type (2022-2027)
5 Ebola Treatment Breakdown Data by Application
5.1 Global Ebola Treatment Historic Market Size by Application (2016-2021)
5.2 Global Ebola Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ebola Treatment Market Size (2016-2027)
6.2 North America Ebola Treatment Market Size by Type
6.2.1 North America Ebola Treatment Market Size by Type (2016-2021)
6.2.2 North America Ebola Treatment Market Size by Type (2022-2027)
6.2.3 North America Ebola Treatment Market Size by Type (2016-2027)
6.3 North America Ebola Treatment Market Size by Application
6.3.1 North America Ebola Treatment Market Size by Application (2016-2021)
6.3.2 North America Ebola Treatment Market Size by Application (2022-2027)
6.3.3 North America Ebola Treatment Market Size by Application (2016-2027)
6.4 North America Ebola Treatment Market Size by Country
6.4.1 North America Ebola Treatment Market Size by Country (2016-2021)
6.4.2 North America Ebola Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Ebola Treatment Market Size (2016-2027)
7.2 Europe Ebola Treatment Market Size by Type
7.2.1 Europe Ebola Treatment Market Size by Type (2016-2021)
7.2.2 Europe Ebola Treatment Market Size by Type (2022-2027)
7.2.3 Europe Ebola Treatment Market Size by Type (2016-2027)
7.3 Europe Ebola Treatment Market Size by Application
7.3.1 Europe Ebola Treatment Market Size by Application (2016-2021)
7.3.2 Europe Ebola Treatment Market Size by Application (2022-2027)
7.3.3 Europe Ebola Treatment Market Size by Application (2016-2027)
7.4 Europe Ebola Treatment Market Size by Country
7.4.1 Europe Ebola Treatment Market Size by Country (2016-2021)
7.4.2 Europe Ebola Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ebola Treatment Market Size (2016-2027)
8.2 Asia-Pacific Ebola Treatment Market Size by Type
8.2.1 Asia-Pacific Ebola Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ebola Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ebola Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Ebola Treatment Market Size by Application
8.3.1 Asia-Pacific Ebola Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ebola Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ebola Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Ebola Treatment Market Size by Region
8.4.1 Asia-Pacific Ebola Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ebola Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ebola Treatment Market Size (2016-2027)
9.2 Latin America Ebola Treatment Market Size by Type
9.2.1 Latin America Ebola Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Ebola Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Ebola Treatment Market Size by Type (2016-2027)
9.3 Latin America Ebola Treatment Market Size by Application
9.3.1 Latin America Ebola Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Ebola Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Ebola Treatment Market Size by Application (2016-2027)
9.4 Latin America Ebola Treatment Market Size by Country
9.4.1 Latin America Ebola Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Ebola Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ebola Treatment Market Size (2016-2027)
10.2 Middle East & Africa Ebola Treatment Market Size by Type
10.2.1 Middle East & Africa Ebola Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ebola Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ebola Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Ebola Treatment Market Size by Application
10.3.1 Middle East & Africa Ebola Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ebola Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ebola Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Ebola Treatment Market Size by Country
10.4.1 Middle East & Africa Ebola Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ebola Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Arbutus Biopharma
11.1.1 Arbutus Biopharma Company Details
11.1.2 Arbutus Biopharma Business Overview
11.1.3 Arbutus Biopharma Ebola Treatment Introduction
11.1.4 Arbutus Biopharma Revenue in Ebola Treatment Business (2016-2021)
11.1.5 Arbutus Biopharma Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Ebola Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Ebola Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Details
11.3.2 Johnson & Johnson Services Business Overview
11.3.3 Johnson & Johnson Services Ebola Treatment Introduction
11.3.4 Johnson & Johnson Services Revenue in Ebola Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Services Recent Development
11.4 Hemispherx Biopharma
11.4.1 Hemispherx Biopharma Company Details
11.4.2 Hemispherx Biopharma Business Overview
11.4.3 Hemispherx Biopharma Ebola Treatment Introduction
11.4.4 Hemispherx Biopharma Revenue in Ebola Treatment Business (2016-2021)
11.4.5 Hemispherx Biopharma Recent Development
11.5 BioCryst Pharmaceuticals
11.5.1 BioCryst Pharmaceuticals Company Details
11.5.2 BioCryst Pharmaceuticals Business Overview
11.5.3 BioCryst Pharmaceuticals Ebola Treatment Introduction
11.5.4 BioCryst Pharmaceuticals Revenue in Ebola Treatment Business (2016-2021)
11.5.5 BioCryst Pharmaceuticals Recent Development
11.6 NanoViricides
11.6.1 NanoViricides Company Details
11.6.2 NanoViricides Business Overview
11.6.3 NanoViricides Ebola Treatment Introduction
11.6.4 NanoViricides Revenue in Ebola Treatment Business (2016-2021)
11.6.5 NanoViricides Recent Development
11.7 NewLink Genetics
11.7.1 NewLink Genetics Company Details
11.7.2 NewLink Genetics Business Overview
11.7.3 NewLink Genetics Ebola Treatment Introduction
11.7.4 NewLink Genetics Revenue in Ebola Treatment Business (2016-2021)
11.7.5 NewLink Genetics Recent Development
11.8 Chimerix
11.8.1 Chimerix Company Details
11.8.2 Chimerix Business Overview
11.8.3 Chimerix Ebola Treatment Introduction
11.8.4 Chimerix Revenue in Ebola Treatment Business (2016-2021)
11.8.5 Chimerix Recent Development
11.9 Sarepta Therapeutics
11.9.1 Sarepta Therapeutics Company Details
11.9.2 Sarepta Therapeutics Business Overview
11.9.3 Sarepta Therapeutics Ebola Treatment Introduction
11.9.4 Sarepta Therapeutics Revenue in Ebola Treatment Business (2016-2021)
11.9.5 Sarepta Therapeutics Recent Development
11.10 Mapp Biopharmaceutical
11.10.1 Mapp Biopharmaceutical Company Details
11.10.2 Mapp Biopharmaceutical Business Overview
11.10.3 Mapp Biopharmaceutical Ebola Treatment Introduction
11.10.4 Mapp Biopharmaceutical Revenue in Ebola Treatment Business (2016-2021)
11.10.5 Mapp Biopharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ebola Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vaccine (Under Trials)
Table 3. Key Players of Drugs (Under Trials)
Table 4. Global Ebola Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Ebola Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ebola Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Ebola Treatment Market Share by Regions (2016-2021)
Table 8. Global Ebola Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Ebola Treatment Market Share by Regions (2022-2027)
Table 10. Ebola Treatment Market Trends
Table 11. Ebola Treatment Market Drivers
Table 12. Ebola Treatment Market Challenges
Table 13. Ebola Treatment Market Restraints
Table 14. Global Ebola Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Ebola Treatment Market Share by Players (2016-2021)
Table 16. Global Top Ebola Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ebola Treatment as of 2020)
Table 17. Ranking of Global Top Ebola Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Ebola Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ebola Treatment Product Solution and Service
Table 21. Date of Enter into Ebola Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ebola Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Ebola Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Ebola Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Ebola Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Ebola Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Ebola Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Ebola Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Ebola Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Ebola Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Ebola Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Ebola Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Ebola Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Ebola Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Ebola Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Ebola Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Ebola Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Ebola Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Ebola Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Ebola Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Ebola Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Ebola Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Ebola Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ebola Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ebola Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ebola Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Ebola Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Ebola Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Ebola Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Ebola Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Ebola Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Ebola Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Ebola Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Ebola Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Ebola Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ebola Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ebola Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ebola Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Ebola Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Arbutus Biopharma Company Details
Table 62. Arbutus Biopharma Business Overview
Table 63. Arbutus Biopharma Ebola Treatment Product
Table 64. Arbutus Biopharma Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 65. Arbutus Biopharma Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Ebola Treatment Product
Table 69. GlaxoSmithKline Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Johnson & Johnson Services Company Details
Table 72. Johnson & Johnson Services Business Overview
Table 73. Johnson & Johnson Services Ebola Treatment Product
Table 74. Johnson & Johnson Services Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Services Recent Development
Table 76. Hemispherx Biopharma Company Details
Table 77. Hemispherx Biopharma Business Overview
Table 78. Hemispherx Biopharma Ebola Treatment Product
Table 79. Hemispherx Biopharma Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 80. Hemispherx Biopharma Recent Development
Table 81. BioCryst Pharmaceuticals Company Details
Table 82. BioCryst Pharmaceuticals Business Overview
Table 83. BioCryst Pharmaceuticals Ebola Treatment Product
Table 84. BioCryst Pharmaceuticals Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 85. BioCryst Pharmaceuticals Recent Development
Table 86. NanoViricides Company Details
Table 87. NanoViricides Business Overview
Table 88. NanoViricides Ebola Treatment Product
Table 89. NanoViricides Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 90. NanoViricides Recent Development
Table 91. NewLink Genetics Company Details
Table 92. NewLink Genetics Business Overview
Table 93. NewLink Genetics Ebola Treatment Product
Table 94. NewLink Genetics Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 95. NewLink Genetics Recent Development
Table 96. Chimerix Company Details
Table 97. Chimerix Business Overview
Table 98. Chimerix Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 99. Chimerix Recent Development
Table 100. Sarepta Therapeutics Company Details
Table 101. Sarepta Therapeutics Business Overview
Table 102. Sarepta Therapeutics Ebola Treatment Product
Table 103. Sarepta Therapeutics Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 104. Sarepta Therapeutics Recent Development
Table 105. Mapp Biopharmaceutical Company Details
Table 106. Mapp Biopharmaceutical Business Overview
Table 107. Mapp Biopharmaceutical Ebola Treatment Product
Table 108. Mapp Biopharmaceutical Revenue in Ebola Treatment Business (2016-2021) & (US$ Million)
Table 109. Mapp Biopharmaceutical Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ebola Treatment Market Share by Type: 2020 VS 2027
Figure 2. Vaccine (Under Trials) Features
Figure 3. Drugs (Under Trials) Features
Figure 4. Global Ebola Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgery Centres Case Studies
Figure 7. Specialized Clinics Case Studies
Figure 8. Army Camps (Veteran Facilities) Case Studies
Figure 9. Ebola Treatment Report Years Considered
Figure 10. Global Ebola Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Ebola Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Ebola Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Ebola Treatment Market Share by Regions (2022-2027)
Figure 14. Global Ebola Treatment Market Share by Players in 2020
Figure 15. Global Top Ebola Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ebola Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Ebola Treatment Revenue in 2020
Figure 17. Global Ebola Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Ebola Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Ebola Treatment Market Share by Type (2016-2027)
Figure 21. North America Ebola Treatment Market Share by Application (2016-2027)
Figure 22. North America Ebola Treatment Market Share by Country (2016-2027)
Figure 23. United States Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ebola Treatment Market Share by Type (2016-2027)
Figure 27. Europe Ebola Treatment Market Share by Application (2016-2027)
Figure 28. Europe Ebola Treatment Market Share by Country (2016-2027)
Figure 29. Germany Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ebola Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Ebola Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Ebola Treatment Market Share by Region (2016-2027)
Figure 39. China Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ebola Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Ebola Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Ebola Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ebola Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Ebola Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Ebola Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Ebola Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Arbutus Biopharma Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Services Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 61. Hemispherx Biopharma Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 62. BioCryst Pharmaceuticals Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 63. NanoViricides Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 64. NewLink Genetics Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 65. Chimerix Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 66. Sarepta Therapeutics Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 67. Mapp Biopharmaceutical Revenue Growth Rate in Ebola Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の牛乳アレルギー臨床試験レビュー市場規模・現状・予測（2021年-2027年） Cow’s milk allergy (CMA) is among the most common FA in early childhood, with an estimated prevalence of 2% to 3%. The mission for Milk Allergy Clinical Trials is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases. Market Ana…- 世界の臨床試験市場規模・現状・予測（2021年-2027年） Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like a new drug or diet or medical device (for example, a pacemaker) is safe and effective in …
- 世界のe-臨床試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global e-clinical Trials Market The global e-clinical Trials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界の臨床試験画像市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Clinical Trials Imaging Market The global Clinical Trials Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の臨床試験画像市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Clinical Trials Imaging Market The global Clinical Trials Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…